Literature DB >> 7699416

Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs.

A T Myklebust1, A Helseth, K Breistøl, W A Hall, O Fodstad.   

Abstract

Models for hematogenous spread of human cancer to the central nervous system (CNS) were established by injecting human tumor cells into the internal carotid artery of nude rats. With 4 out of 10 cell lines, belonging to four different tumor types, metastases developed in all injected animals. Tumor growth manifested clinically as neurological symptoms which appeared after a median latency ranging from 19-87 days for the different tumors. The H-146 and DMS-273 small cell lung cancers and the LOX melanoma almost exclusively gave meningeal tumors, whereas with FEMX-I melanoma cells bone metastases in the skull dominated. For these tumor types a correlation was found between the capacity for experimental metastasis formation and the s.c. tumorigenicity. In agreement with clinical experience, none of the 2 sarcoma and 2 glioblastoma lines gave CNS metastases. With a modified microsurgical technique, allowing for repeated ipsilateral intracarotid injections, we analyzed the drug concentrations obtained in tumor and surrounding brain tissue after i.v. treatment with doxorubicin. The concentration in the LOX tumor reached therapeutic levels and was approximately 100 x higher than in normal brain tissue, both with and without intraarterial pretreatment with arabinose. In the same model, the tissue concentrations of 9.2.27-abrin immunotoxin 10 min after intracarotid injection were examined. Although the levels were low, a tumor to brain concentration ratio of up to 9 was achieved. The data demonstrate that clinically relevant tumor models can be established with the techniques described, and these models may successfully be used to evaluate the pharmacokinetics and effect of intravenous or intraarterial therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699416     DOI: 10.1007/bf01063770

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma.

Authors:  R H Shoemaker; D J Dykes; J Plowman; S D Harrison; D P Griswold; B J Abbott; J G Mayo; O Fodstad; M R Boyd
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

2.  Different metastasis patterns of a human melanoma cell line in nude mice and rats: influence of microenvironment.

Authors:  I Kjønniksen; H K Høifødt; A Pihl; O Fodstad
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

3.  Human brain tumor transplantation into nude mice.

Authors:  W R Shapiro; G A Basler; N L Chernik; J B Posner
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

4.  Quantitative aspects of reversible osmotic opening of the blood-brain barrier.

Authors:  S I Rapoport; W R Fredericks; K Ohno; K D Pettigrew
Journal:  Am J Physiol       Date:  1980-05

5.  Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice.

Authors:  G Schackert; J E Price; C D Bucana; I J Fidler
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

6.  Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals.

Authors:  G Schackert; I J Fidler
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

Review 7.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

8.  Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.

Authors:  A Godal; O Fodstad; A C Morgan; A Pihl
Journal:  J Natl Cancer Inst       Date:  1986-12       Impact factor: 13.506

9.  Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma.

Authors:  O Fodstad; A Brøgger; O Bruland; O P Solheim; J M Nesland; A Pihl
Journal:  Int J Cancer       Date:  1986-07-15       Impact factor: 7.396

10.  Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.

Authors:  A T Myklebust; A Godal; O Fodstad
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 13.312

View more
  11 in total

1.  Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis.

Authors:  Vladimir N Ivanov; Ze'ev Ronai; Tom K Hei
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

Review 2.  Animal models of leptomeningeal metastasis.

Authors:  M Schabet; U Herrlinger
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

3.  Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Apoptosis       Date:  2011-12       Impact factor: 4.677

4.  Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.

Authors:  Nancy D Doolittle; David M Peereboom; Gregory A Christoforidis; Walter A Hall; Diane Palmieri; Penelope R Brock; Kathleen C M Campbell; D Thomas Dickey; Leslie L Muldoon; Brian Patrick O'Neill; Darryl R Peterson; Brad Pollock; Carole Soussain; Quentin Smith; Rose Marie Tyson; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2006-07-21       Impact factor: 4.130

5.  Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

6.  Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Apoptosis       Date:  2015-07       Impact factor: 4.677

7.  Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Exp Cell Res       Date:  2006-02-17       Impact factor: 3.905

8.  Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  J Biol Chem       Date:  2004-03-17       Impact factor: 5.157

9.  Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.

Authors:  Xu Wan; Xiaoyao Zheng; Xiaoyin Pang; Zhiqing Pang; Jingjing Zhao; Zheming Zhang; Tao Jiang; Wei Xu; Qizhi Zhang; Xinguo Jiang
Journal:  Oncotarget       Date:  2016-06-07

10.  Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method.

Authors:  Zongming Liu; Yanzhi Wang; Sheheryar Kabraji; Shaozhen Xie; Peichen Pan; Zhenning Liu; Jing Ni; Jean J Zhao
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.